Mar 10, 2022 / 03:00PM GMT
Operator
Ladies and gentlemen, thank you for standing by, and welcome to Zealand Pharma Fourth Quarter and Full Year '20 (sic) ['21] Earnings Conference Call. (Operator Instructions)
I would now like to hand the conference over to your speaker today, Emmanuel Dulac. Please go ahead, sir.
Emmanuel Dulac - Zealand Pharma A/S-CEO&President
Yes. Good afternoon, everyone. Yes. Please, Matt, take it over.
Matthew Donald Dallas - Zealand Pharma A/S-Senior VP&CFO
All right. Thank you. Thanks, Emmanuel. Welcome, and thank you for joining us today to discuss Zealand's fourth quarter and full year results for 2021. I'm Matt Dallas, Senior Vice President and Chief Financial Officer at Zealand.
With me today are Zealand's President and Chief Executive Officer, Emmanuel Dulac; President of Zealand Pharma U.S., Frank Sanders; and Chief Medical Officer and Head of Development, Adam Steensberg. You can find the
Q4 2021 Zealand Pharma A/S Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
